Post ChAdOx1 nCoV-19 vaccination frontal lobe syndrome
Sign Up to like & getrecommendations! Published in 2022 at "Neurological Sciences"
DOI: 10.1007/s10072-022-06086-9
Abstract: Dear Editor, The stepping up of an effective mass vaccination programme against the novel SARS-CoV-2 virus worldwide has led to the emergence of a host of adverse events involving various systems, a majority of which… read more here.
Keywords: lobe syndrome; frontal lobe; ncov vaccination; chadox1 ncov ... See more keywords
Durability of ChAdOx1 nCov-19 vaccination in people living with HIV.
Sign Up to like & getrecommendations! Published in 2022 at "JCI insight"
DOI: 10.1172/jci.insight.157031
Abstract: Duration of protection from SARS-CoV-2 infection in people with HIV (PWH) following vaccination is unclear. In a sub-study of the phase 2/3 the COV002 trial (NCT04400838), 54 HIV positive male participants on antiretroviral therapy (undetectable… read more here.
Keywords: chadox1 ncov; sars cov; durability chadox1; vaccination ... See more keywords
A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination
Sign Up to like & getrecommendations! Published in 2021 at "Blood"
DOI: 10.1182/blood.2021012064
Abstract: Vaccination is crucial in combatting the SARS-CoV-2 pandemic. The rare complication of thrombocytopenia and thrombotic complications at unusual sites after ChAdOx1 nCov-19 vaccination is caused by platelet-activating antibodies directed against platelet factor 4. We present… read more here.
Keywords: platelet activating; chadox1 ncov; ncov vaccination; vaccination ... See more keywords
Safety of ChAdOx1 nCoV-19 vaccination in patients with end-stage renal disease on hemodialysis
Sign Up to like & getrecommendations! Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0273676
Abstract: Background COVID-19 vaccination is essential. However, no study has reported adverse events (AEs) after ChAdOx1 nCoV-19 vaccination in patients with end-stage renal disease (ESRD) on hemodialysis (HD). This study investigated the AEs within 30-days after… read more here.
Keywords: safety; chadox1 ncov; vaccination; vaccination patients ... See more keywords
Cerebral venous thrombosis after ChAdOx1 nCoV-19 vaccination: a systematic review.
Sign Up to like & getrecommendations! Published in 2023 at "European review for medical and pharmacological sciences"
DOI: 10.26355/eurrev_202301_30894
Abstract: OBJECTIVE To perform a systematic review of case reports or case series regarding thrombosis with thrombocytopenia syndrome (TTS) and cerebral venous thrombosis (CVT) related to ChAdOx1 nCoV-19 vaccination to address the clinical features, laboratory findings,… read more here.
Keywords: chadox1 ncov; review; ncov vaccination; cvt ... See more keywords
Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan
Sign Up to like & getrecommendations! Published in 2022 at "Vaccines"
DOI: 10.3390/vaccines10020312
Abstract: Background: The ChAdOx1 nCoV-19 vaccine has been widely administered against SARS-CoV-2 infection; however, data regarding its immunogenicity, reactogenicity, and potential differences in responses among Asian populations remain scarce. Methods: 270 participants without prior COVID-19 were… read more here.
Keywords: ncov vaccination; chadox1 ncov; immunogenicity reactogenicity; vaccination ... See more keywords
Elevated NETs and Calprotectin Levels after ChAdOx1 nCoV-19 Vaccination Correlate with the Severity of Side Effects
Sign Up to like & getrecommendations! Published in 2022 at "Vaccines"
DOI: 10.3390/vaccines10081267
Abstract: ChAdOx1 nCoV-19 vaccination has been associated with the rare side effect; vaccine-induced immune thrombotic thrombocytopenia (VITT). The mechanism of thrombosis in VITT is associated with high levels of neutrophil extracellular traps (NETs). The present study… read more here.
Keywords: chadox1 ncov; vaccination; ncov vaccination; side effects ... See more keywords